Announce Date | 02/27/2025 |
EPS Normalized Actual | $0.38 (Miss by $-0.02) |
EPS GAAP Actual | $0.38 (Miss by $-0.02) |
Revenue Actual | $1.81204B |
Revenue Surprise | Beat by $1812.04M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 3.24 | 17.62 | 3.07622 | 3.36955 | 4 |
Dec 2027 | 2.55951 | 22.3 | 2.43013 | 2.66185 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 1.81204B | -180.12% | 1812.04M |
FQ3 2024 (Sep 2024) | 0.38 | 0.38 | 2.76215B | 32.8% | 2762.15M |
FQ2 2024 (Jun 2024) | 0.41 | 0.41 | 1.9006B | 2.4% | 1900.6M |
FQ1 2024 (Mar 2024) | 0.42 | 0.42 | 1.8991B | 10.54% | 1899.1M |
FQ4 2023 (Dec 2023) | 0.35 | 0.35 | 5.07593B | 70.19% | 5075.93M |
FQ3 2023 (Sep 2023) | 0.43 | 0.43 | 1.85603B | 12.49% | 1856.03M |
FQ2 2023 (Jun 2023) | 0.4 | 0.4 | 1.85496B | 10.77% | 1854.96M |
FQ1 2023 (Mar 2023) | 0.38 | 0.38 | 1.69893B | 100% | 1698.93M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0 | -- | 0 | 0 | 7 |
FQ3 2027 (Jul 2027) | 0 | -- | 0 | 0 | 6 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 5 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 5 |
FQ4 2026 (Oct 2026) | 0.61595 | -- | 0.57866 | 0.6467 | 5 |
FQ3 2026 (Jul 2026) | 0.59633 | -- | 0.56023 | 0.6261 | 5 |
FQ2 2026 (Jun 2026) | 0.6004 | -- | 0.56581 | 0.62918 | 5 |
FQ1 2026 (Mar 2026) | 0.54147 | -- | 0.51027 | 0.56742 | 11 |
FQ4 2025 (Oct 2025) | 0.53532 | 47.69 | 0.50291 | 0.56204 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.48B | -- | 2.34B | 2.56B | 6 |
FQ3 2027 (Jul 2027) | 2.49B | -- | 2.35B | 2.57B | 6 |
FQ2 2027 (Jun 2027) | 2.49B | -- | 2.35B | 2.61B | 6 |
FQ1 2027 (Mar 2027) | 2.28B | -- | 2.15B | 2.39B | 6 |
FQ4 2026 (Oct 2026) | 2.47B | -- | 2.35B | 2.56B | 6 |
FQ3 2026 (Jul 2026) | 2.47B | -- | 2.35B | 2.56B | 6 |
FQ2 2026 (Jun 2026) | 2.49B | -- | 2.38B | 2.59B | 10 |
FQ1 2026 (Mar 2026) | 2.28B | -- | 2.18B | 2.36B | 10 |
FQ4 2025 (Oct 2025) | 2.25B | 19.42 | 2.14B | 2.34B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 100% | |
FQ3 2024 (Sep 2024) | 0.38 | 0.38 | 100% | |
FQ2 2024 (Jun 2024) | 0.41 | 0.41 | 100% | |
FQ1 2024 (Mar 2024) | 0.42 | 0.42 | 100% | |
FQ4 2023 (Dec 2023) | 0.35 | 0.35 | 100% | |
FQ3 2023 (Sep 2023) | 0.43 | 0.43 | 100% | |
FQ2 2023 (Jun 2023) | 0.4 | 0.4 | 100% | |
FQ1 2023 (Mar 2023) | 0.38 | 0.38 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $1.81B | $1812.04M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.76B | $2762.15M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.9B | $1900.6M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.9B | $1899.1M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.08B | $5075.93M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.86B | $1856.03M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.85B | $1854.96M | 100% |
FQ1 2023 (Mar 2023) | $0B | $1.7B | $1698.93M | 100% |